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Abstract
There is increasing evidence linking the gut microbiota to various aspects of human health. Nuts are a food rich in prebiotic fibre and poly-
phenols, food components which have been shown to have beneficial effects on the gut microbiota. This systematic review aimed to synthesise
the evidence regarding the effect of nut consumption on the human gut microbiota. A systematic search of the databases MEDLINE, PubMed,
Cochrane CENTRAL and CINAHL was performed until 28 November 2019. Eligible studies were those that investigated the effects of nut con-
sumption in humans (aged over 3 years old), utilising next-generation sequencing technology. Primary outcomemeasures were between-group
differences in α- and β-diversity metrics and gut microbial composition. A total of eight studies were included in the review. Included studies
assessed the effects of either almonds, walnuts, hazelnuts or pistachios on the gut microbiota. Overall, nut consumption had amodest impact on
gut microbiota diversity, with two studies reporting a significant shift in α-diversity and four reporting a significant shift in β-diversity. Walnuts, in
particular, appeared tomore frequently explain shifts in β-diversity, whichmay be a result of their unique nutritional composition. Some shifts in
bacterial composition (including an increase in genera capable of producing SCFA: Clostridium, Roseburia, Lachnospira and Dialister) were
reported following the consumption of nuts. Nut intake may yield a modulatory effect on the gut microbiota; however, results were inconsistent
across studies, which may be explained by variations in trial design, methodological limitations and inter-individual microbiota.
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The gut microbiome is a rapidly expanding area of human
research(1). While often used interchangeably(2), the term gut
‘microbiome’ refers to all of themicrobial genes that reside inside
the gastrointestinal tract, while the microbes themselves are col-
lectively known as the ‘microbiota’. Being a complex and meta-
bolically active ecosystem, these microbes generally maintain a
symbiotic relationship with the host and participate in a number
of beneficial functions within the body. These include the syn-
thesis of vitamins(3), regulating the immune system(4) and pro-
duction of SCFA, which are a key energy source for colonic
epithelial cells(5). Interestingly, several health conditions have
been linked with alterations in the gut microbiota populations,
including type 2 diabetes(6,7), obesity(8,9) and inflammatory
bowel disease(10); however, it is unclear if this dysbiosis is a cause
or consequence of the disease(11).
Relatively recent advancements in techniques used to charac-
terise the composition of the microbiota have provided a greater
understanding of host–gutmicrobiotametabolic interactions and
its subsequent effect on human physiology. Since 2005,
advancements in microbial determination methods, in particular
high-throughput sequencing techniques, have vastly improved
the understanding of the gut microbiota, by allowing a more
comprehensive investigation of phylogenetic composition and
quantification(12). Examples of this technology include the
next-generation sequencing of the 16s rRNA gene or its ampli-
cons, which are based on sequence divergences of the small
subunit rRNA(13).
Given the potential impact of the gut microbiome on human
health and disease, there is a need to identify foods which may
support a healthymicrobiome. Previous research has shown that
prebiotic fibres are a key substrate facilitating change in the
microbiome(14). In humans, prebiotic fibre escapes digestion
in the small intestine and instead passes into the colon where
it is used as a substrate by the microbes. Here, it stimulates
the growth of specific organisms leading to the production of dif-
ferent metabolites, including the SCFA butyrate, which confers
health benefits to the host(15).
Nut consumption is associated with many positive health
benefits(16). Both epidemiological studies and clinical trials have
linked frequent nut consumption to a reduced risk of developing
Abbreviations: OTU, operational taxonomic unit; UM, urolithin metabotype.
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type 2 diabetes(17) and CHD(18), as well as a reduction in cardio-
vascular risk factors such as hypertension(19) and the promotion
of a more beneficial lipid profile(20). Nuts are nutrient dense and
contain high amounts of plant-based protein, unsaturated fatty
acids, vitamins, minerals and other phytochemicals(21). Nuts
have the second highest fibre content of all foods per 100 g,
behind cereals(22). Nuts are also a food source rich in polymer-
ised polyphenols(23), resistant starch(24) and NSP(25), which
appear to have a prebiotic effect. Additionally, walnuts are par-
ticularly high in n-3 fatty acids, with preliminary research classi-
fying these fatty acids as prebiotics(26). While the health benefits
of nuts may in part be due to their unique nutritional composi-
tion, the exact mechanism by which nuts exert this range of ben-
eficial health effects remains unclear. Previous trials have
examined the specific microbial shifts that occur with nut con-
sumption(27–34); however, due to inconsistency of study findings,
there is a need to evaluate the evidence base. The present sys-
tematic review aimed to synthesise the existing evidence regard-
ing the effect of nut consumption (tree nuts and peanuts) on the
gut microbiota of humans. We hypothesise that due to the array
of prebiotic compounds, supplementation of the diet with nuts
promotes the proliferation of beneficial microbial species, lead-
ing to favourable changes in the gut microbiota.
Methods
This systematic review was reported according to the guidelines
of the Preferred Reporting Items for Systematic Reviews and
Meta-Analysis statement(35). The review protocol was prospec-
tively registered in PROSPERO (International Prospective
Register of Systematic Reviews) protocol no. CRD42019127318.
Literature search
A systematic search of the electronic databases MEDLINE
(EBSCO), PubMed, Cochrane CENTRAL and CINAHL (EBSCO)
was performed until 28 November 2019, using a combination
of MeSH and individual search terms. No date or language
restrictionwas applied in the search strategy. In conjunctionwith
searching the electronic databases, additional hand searching of
the reference lists of relevant articles was also performed. An
example search strategy is presented in online Supplementary
Data 1.
Study selection
All search results were exported from the electronic databases
into the reference management software ENDNOTE (X9;
Thomson Reuters), and duplicates were then removed.
Eligible studies were identified by two review authors (EF and
EN) who screened articles independently based on title and
abstract. Full texts were then retrieved, and the eligibility criteria
were applied to the full-text articles. Discrepancies were
resolved by consensus or consultation with a third party (KL).
Studies were included if they met all of the following criteria:
(1) human studies involving participants aged more than 3 years
old. This broad age range was used due to findings showing that
the gut microbiota of children resembles that of an adult after
3 years of age(36); (2) nuts were administered in their whole form
or minimally processed to still contain all components of the
whole nut (e.g. nut butters, roasted, ground or chopped nuts);
(3) consumption of nuts was compared with no consumption
of nuts or a lower quantity of nuts; (4) study design was in the
form of randomised or non-randomised experiments, cross-
sectional or cohort studies and (5) outcomes were measured
using next-generation DNA sequencing technologies, including
both targeted amplicon sequencing and shotgun metagenomics.
Studies were restricted to those that used these methods as they
provide themost comprehensive analysis of themicrobiota, ena-
bling taxonomic quantification and identification. Additionally,
limiting to these methods provided ameans of promoting homo-
geneity between study results, considering the range of micro-
biota characterisation techniques available and the subsequent
differences in reporting of outcome measurements(12).
In addition to the inclusion criteria outlined above, the fol-
lowing exclusion criteria were applied: (1) in vitro experiments
and animal studies due to the limited applicability of these results
to the human microbiota, (2) experiments where nut intake
could not be isolated from other interventions (e.g. other dietary
interventions) and (3) studies which only measured changes in
the microbiota-related metabolites. In addition, studies which
included both nuts in their whole form and isolated nut compo-
nents (such as oils or extracts) were only included if data from
nuts in their whole form could be differentiated.
Outcome measures
Primary outcome measures were between-group differences in
α- and β-diversities, as well as statistically significant differences
in the taxonomic composition and microbial abundances at spe-
cific taxonomic levels (phylum, class, order, family, genus or
‘operational taxonomic units’ (OTU). α-Diversity is a measure
of within-sample (or community) diversity, taking into account
the richness and/or evenness of the microbes present(37).
β-Diversity is a measure of microbial dissimilarity between sam-
ples or sites, describing how many taxa are shared between
samples(38).
Data extraction and quality assessment
A tabular summary was developed for the data extraction proc-
ess, which included the population, study design and duration,
nut type format and dosage,method ofmicrobiota determination
and results. Only significant findings (P< 0·05) from each study
reporting changes in microbial composition following nut intake
were recorded. The quality of included studies was assessed
using the Quality Criteria Checklist and Risk of Bias
Assessment Tool by the Academy of Nutrition and Dietetics(39).
Results
Summary of included studies
Searches of the electronic databases returned 894 articles, of
which fifty-six were evaluated after removal of duplicates and
screening of records. A final eight studies met the eligibility cri-
teria and were included in the present review. The above study
selection process is summarised in the Preferred Reporting Items
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for Systematic Reviews and Meta-Analysis 2009 Flow Diagram
(Fig. 1) with the included studies summarised in Table 1 and
described below. For all studies, significant shifts (P< 0·05) in
microbial composition following nut intake are summarised in
Table 2.
Five of the eight studies were randomised controlled cross-
over trials(27,28,31,32,34) with the population group being healthy
adults, one of which also included healthy children(32). All of
these studies utilised a washout period, ranging from 1 to
6 weeks, in between treatment periods. The remaining three
studies consisted of a parallel design randomised controlled
trial(33) and two pre-test/post-test studies(29,30). Studies were pre-
dominantly published in the USA(27,31–34) (n 5/8), with one being
published in Germany(28), one in Italy(30) and one in Spain(29).
Sample sizes ranged from n 15 to 194, with the proportion of
female participants in each study ranging from 28 to 83 %.
Feeding periods within studies ranged from 3 d to 8 weeks, with
overall study length ranging from 3 d up to 24 weeks. Three stud-
ies examined the effect of whole walnut consumption on the gut
microbiota(27–29), one study utilised whole roasted hazelnuts(30),
three studies(31–33) investigated almonds in varying forms of the
whole nut and one study utilised both whole almonds or
pistachios(34). Nut dose in adult participants varied from
approximately one serving (33 g/d) up to two servings daily
(84 g), with the dosage being adapted for children. In most stud-
ies, the rationale for nut dosagewas due to this serving size (42 or
43 g, or 1·5 oz) being consistent with the US Food and Drug
Administration qualified health claim for nuts and CVD(40).
All eligible studies assessed the gut microbiota using high-
throughput sequencing technology, with all studies sequencing
the 16s rRNA gene to determine bacterial composition. Seven
studies used the Illumina Miseq(27–33), whereas one used 454-
based pyrosequencing platform(34). In addition, three studies
reported on microbial communities other than bacteria with
one study also sequencing fungal DNA(34) (using primers
directed against the IS4 and IS5 inter-spacer regions), and two
studies sequencing both fungal (ITS1–ITS4) and archaeal (16s
rRNA gene using 349f/806r primers) DNA(27,31). All studies mea-
sured α-diversity using one or a combination of indices
(Simpson’s index, Shannon index, Chao-1 index, Faith’s phylo-
genic diversity or observed OTU). Reported measures of
β-diversity used across included studies were the UniFrac and
Bray-Curtis distance metrics.
Using the Academy of Nutrition and Dietetics Evidence
AnalysisManualQuality Criteria Checklist, six of the eight studies







































Full-text articles excluded, with
reason
(n 48)
Not possible to isolated the effects of nuts n 7
Conference abstract only n 5
Only measured microbial metabolites n 10
Study protocol only n 11
Included nut extracts n 1
Not appropriate study design n 8
Not reporting outcome of interest n 4
In vitro experiments n 2
Fig. 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of study selection.
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remaining two studies(29,32) found to be of neutral quality (online
Supplementary Data 2).
Microbiota diversity metrics and bacterial composition,
by nut type
Walnuts. Following consumption of 42 g of walnuts per d for
3 weeks, Holscher et al.(27) found no significant shifts in
α-diversity, a measure of within-sample diversity; however, bac-
terial communities were significantly affected by walnut con-
sumption when β-diversity, a measure of microbial dissimilarity
between samples was analysed, as evidenced by aweighted prin-
cipal coordinate analysis of UniFrac distances (P= 0·03). No sig-
nificant differences in fungal or archaeal abundances were found
following walnut intake. A significant decrease in the relative
abundance of Actinobacteria was observed, with the relative
abundance of Firmicutes significantly increasing. At the genus
level, an increased relative abundance of the genera
Faecalibacterium, Clostridium, Roseburia (Clostridium clusters
XIVa and IV) and Dialister (49–160% higher relative abundance)
was found, whereas the relative abundances of the genera
Ruminococcus, Dorea, Oscillospira and Bifidobacterium were
significantly decreased (16–38% lower relative abundance).
Utilising 43 g of walnuts per d over an 8-week period,
Bamberger et al.(28) reported a significant shift in β-diversity only.
Using the generalised UniFrac distance metric and the
PERMANOVA statistical test, significant dissimilarity of approxi-
mately 5 % between the walnut and control groups (P= 0·02)
was found. No significant differences in predominant phyla or
the Firmicutes:Bacteroidetes ratio were observed. Significant
shifts in the relative abundance could be seen in four OTUs,
which are clusters of similar sequences used to categorise bac-
teria, of the phyla Firmicutes and one OTU of the phyla
Actinobacteria, which decreased. A significant increase was
found in two unclassified OTUs from the Ruminococcaceae fam-
ily (P< 0·02), as well as an increase in an OTU from the
Table 2. Significant shifts in the gut microbial composition following nut intake













































↓Unclassified member closest to Clostridium sp.
ASF356(34)
↓Unclassified OTU (Candida tropicalis)(34)
↓Unclassified OTU (uncultured soil fungus)(34)
Pistachio:
↓Unclassified member closest to Firmicutes DJF VP44(34)
↓Unclassified OTU (Aspergillus fumigates)(34)
↓Unclassified OTU (Penicillium roqueforti)(34)
↓Unclassified OTU (Penicillium commune)(34)
↓Unclassified OTU (uncultured compost fungus)(34)
↓Unclassified OTU (Saccharomyces cerevisiae)(34)
↓Unclassified OTU (Candida sake)(34)
↓Unclassified OTU (Dipodascus capitatus)(34)
↓, Reported decrease in abundance/relative abundance; ↑, reported increase in abundance/relative abundance; OTU, operational taxonomic unit.
† Results for UM-A only.
‡ Results for UM-B only.
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Bifidobacterium genus (P< 0·02). A significant decrease was
found in the relative abundance of two OTUs, Anaerostipes
(P< 0·01) and Blautia (P= 0·04) from the Lachnospiraceae
family.
Garcia-Mantrana et al.(29) examined the effects of 33 g wal-
nuts per d for 3 d on the gut microbiota, reporting results consid-
ering all participants, as well as according to the urolithin
metabotype (UM) of participants, ameasure of how ellagitannins
metabolise to urolithins via the gutmicrobiota. According to their
urinary urolithin concentrations, participants were classified as
either UM-A (characterised by the production of urolithin-A),
UM-B (characterised by the production of urolithin-B) or
UM-0, whereby no urolithins were produced. Local diversity
(Chao-1 index) significantly decreased for both UMs after walnut
consumption and a redundancy analysis of all individuals
revealed that bacterial communities were significantly affected
by walnut intake (P= 0·001). However, when results were
reported according to UM, these shifts were only significant
for UM-B (P= 0·017), suggesting that UM-B was likely a driver
of overall significance. Considering the microbial composition,
walnut intake significantly decreased the relative abundance
of Bacteroidetes, while increasing the abundance of
Actinobacteria. Participants classed as UM-A exhibited a signifi-
cant decrease in the Lachnospiraceae family, as well as a signifi-
cant increase in the genera Coprococcus and Collinsela.
Participants classed as UM-B exhibited a significant increase in
the Coriobacteriaceae family, as well as significant increases in
the genera Coprococcus, Collinsella, Bifidobacterium and
Blautia.
Almonds. Dhillon et al.(33) examined the effects of 57 g roasted
almonds intake on the gutmicrobiota over 6 weeks, with graham
crackers being given to the control group. When considering
α-diversity, almond feeding resulted in significant increases in
the Chao-1 index, observed OTUs and Shannon index, while
the Simpson’s index was significantly decreased. Similarly, sig-
nificant differences in β-diversity between treatment groups
were identified according to unweighted UniFrac distance and
Bray-Curtis dissimilarity metrics. A significant increase was
found in bacteria belonging to the RF39 order, as well as a sig-
nificant decrease in bacteria belonging to the S24.7 family. At the
genus level, a significant decrease in Alistipes, Butyricimonas
and Odoribacter was observed, with a significant increase in
the genera Lachnospira. At the species level, a 48 % decreased
relative abundance of Bacteroides fragilis was reported.
Holscher et al.(31) utilised 42 g of almonds per d in varying
forms over five 3-week diet periods (whole, raw, whole dry
roasted, chopped, dry roasted and dry roasted almond butter),
finding no significant shifts in microbial diversity measures.
Further, no significant differences in fungal or archaeal abundan-
ces were found. Using pooled data, there were no significant
differences in the Firmicutes:Bacteroidetes ratio; however, a sig-
nificant decrease in the relative abundance of Actinobacteriawas
observed. Additionally, results revealed an increased relative
abundance of the genera Roseburia, Clostridium, Dialister
and Lachnospira. A decreased relative abundance of
Parabacteroides and Bifidobacterium was also observed.
When differentiating results by the impact of almond processing,
it was found that chopped almonds increased the relative abun-
dance of Lachnospira, Roseburia and Oscillospira, whole
roasted almonds increased the relative abundance of
Lachnospira and whole raw almonds increased the relative
abundance ofDialister, with no difference between almond but-
ter and controls.
Using both adult and children subjects, Burns et al.(32) used
almonds (an option of whole raw almonds or almond butter
equivalent) over two 3-week diet periods, with adults consum-
ing 43 g/d and children 14 g/d. The present study found no sig-
nificant change in microbial diversity or significant shifts at the
phylum level. However, significant differences in the prevalence
of unclassified bacterial signatures at the genus and species level
were reported.
Hazelnuts. Gargari et al.(30) investigated the effects of nut con-
sumption on the microbiota over an 8-week period in both chil-
dren and adults, using 0·43 g of hazelnuts per d per kg of body
weight, up to a maximum of 30 g of hazelnuts per d. This was the
only study to find no statistically significant differences in micro-
bial diversity or composition of the gut microbiota.
Mixed intervention (almondsþ pistachios). Using a rando-
mised, cross-over design, Ukhanova et al.(34) investigated the
effects of both almond and pistachio consumption on the gut
microbiota, utilising 0, 43 or 85 g/d (equal to 0, 1·5 or 3 serves)
for three 18-d feeding periods. While no significant changes in
α- or β-diversities were reported, the study did report the
pistachio-consuming group to have a greater mean UniFrac dis-
tance (unspecified if weighted or unweighted metric used) com-
pared with the almond-consuming group. This suggests that
pistachios may have had a greater impact on the overall gut
microbiota composition compared with almonds. While many
OTUs were affected by nut consumption, only two were signifi-
cantly decreased: one unspecified OTU closest to the Firmicutes
bacterium DJF VP44 and the other unspecified OTU closest to
Clostridium sp. ASF 356. Nut consumption did not significantly
affect the proportion of the most dominant OTUs. As the present
study also sequenced fungal DNA, it was found that while no
fungal OTU was significantly increased, various fungal OTUs
decreased in proportion (P< 0·01) with nut consumption.
Discussion
To our knowledge, this is the first study to systematically explore
the overall microbiota-related changes related to nut consump-
tion. This review establishes that while the evidence base is
small, intake of nuts in the diet can exert a modulatory effect
on the gut microbiota; however, the exact effects were inconclu-
sive across studies.
Microbial diversity has been shown to be a key predictor of
gut health, as greater diversity often equates to greater resilience
of the community to recover from or adjust to disturbances(41).
On the contrary, a loss of species diversity and an imbalance
in the gut’s microbial community, or ‘dysbiosis’, has commonly
been found in several disease states(9,42). The present systematic
review found that nut intake may have a modest effect on the
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diversity of the gut microbiota, with two(29,33) of the eight total
studies reporting a significant change in α-diversity (one show-
ing a decrease in diversity(29)), and four(27–29,33) reporting a sig-
nificant change in β-diversity. The lack of effect on α-diversity
found in this review is similar to the results of another systematic
review on dietary fibre(14), where short-term feeding studies of
dietary fibre in various forms did not increase α-diversity.
Furthermore, these findings are also comparable to other dietary
intervention studies using whole grains(43,44). Interestingly, one
study(29) included in this review observed a decrease in
α-diversity following a 3-d walnut feeding intervention, a result
comparable to findings from a short-term dietary intervention
advising increased fibre intake(45). The researchers suggested
this temporary reduction in diversity may be due to the rapid
dietary change causing disruption to the microbial composition,
termed the ‘shock effect’. However, these results are in contrast
to previous observational studies that explore the relationship
between overall dietary pattern and gut microbiota diversity.
For example, adherence to the Mediterranean diet has
been associated with increased gastrointestinal bacterial
α-diversity(46,47), a finding of particular relevance given that nuts
are a key component of this dietary pattern. Given that it has
been shown that diet-induced shifts in the gut microbiota occur
within 3–4 d after a change in diet(48), the discrepancies observed
between the short-term interventional trials included in this
review and previous observational studies which assess habitual
diets are unlikely due to the study duration alone. Rather, the dis-
crepanciesmight also be explained by the synergistic effect of an
overall healthy dietary pattern, which appears to be a greater
determinant of gastrointestinal health than just foods or nutrients
in isolation.
Given the variation in the composition of different nut types,
consideration of study results by nut type was warranted.
Different nut types offer unique nutritional profiles, with altered
ratios of fibre, proteins, fat, micronutrients and other bioactive
molecules including polyphenols. Of all the nuts investigated
in the review, walnuts appeared to more frequently explain var-
iations in the overall gut microbial composition between study
participants, with all three of the walnut studies reporting a sig-
nificant shift in relevant β-diversity metrics. While it is difficult to
draw conclusions from this due to the small sample size, the
unique nutritional composition of walnuts as a potential modu-
lator of the gut microbiota should be considered and further
explored in larger interventional trials. For example, walnuts
have a particularly high ellagitannin (a type of polyphenol,
the basic structure being ellagic acid) content compared with
other nuts(49). It has been shown that gastrointestinal bacteria
can metabolise ellagic acid to produce urolithins, which can
have beneficial vascular and anti-inflammatory effects(50,51),
although studies supporting the role of ellagitannins as a pre-
biotic are inconclusive(52,53). Further, it has been shown that dif-
ferent UMs can affect the metabolism and bioactivity of
polyphenols, as demonstrated by Garcia-Mantrana et al.(29).
Walnuts are also particularly rich in the n-3 essential fatty acid
α-linolenic acid(54). Preliminary research on n-3 supplementa-
tion in humans has found these fatty acids to exert significant
effects on gut microbial composition, with the authors conclud-
ing n-3 PUFA may be classified as prebiotics(26). It should be
acknowledged that much of this research was performed using
EPA and DHA, which may be synthesised, albeit often ineffi-
ciently, from α-linolenic acid (55). As a result, the extent to which
α-linolenic acid acts as a possible modulator of the gut micro-
biota remains still unclear.
In the present review, alterations in the gut microbiota pro-
file were reported across a range of different phylogenic cat-
egories, although a lack of consistency across studies was
observed. Nevertheless, some interesting patterns were
observed relating to Bifidobacterium spp. and the SCFA butyr-
ate, which warrants further discussion. Members of the genus
Bifidobacterium are normal inhabitants of the human gastroin-
testinal tract and have demonstrated positive health benefits(56),
largely due to their production of acetate, which has anti-
inflammatory effects and is used by cross-feeding species as
a co-substrate for the production of butyrate(57). Additionally,
research has shown that the loss of Bifidobacterium species in
the gastrointestinal tract has been associatedwith poor bowel out-
comes(58). Given that previous research has found an increased
abundance of Bifidobacterium with increased fibre(14) and poly-
phenol(59,60) intake, the addition of nuts to the diet may have been
expected to produce a bifidogenic effect; however, this effect was
inconsistent. Rather, two studies(27,31) reported a decreased
abundance of Bifidobacterium, one(29) reported a significant
increase in Bifidobacterium for UM-B (when stratified by UM),
and one(28) found an increase in one OTU from the
Bifidobacterium genus. The possible detrimental impact of
walnut consumption on Bifidobacterium may be explained by
inhibition of Bifidobacterium animalis spp. lactis in the presence
of ellagic acid. However, this finding is not universal to the
Bifidobacterium genus and appears to be species-specific(61).
Further, this hypothesis would not explain the findings of
Holscher et al.(31), which observed a decreased abundance of
Bifidobacterium following almond consumption. One significant
gap in the evidence basewhichmay help explain these findings is
the use of more sophisticated multi-omic methods (e.g. shotgun
sequencing and metabolomics), a crucial step in explaining both
the functional potential of the microbiota and the types of metab-
olites these microbes can produce.
Findings of the present review are in contrast to the results of
a recent review by So et al.(14), which found that prebiotic fibre
supplementation consumption increased Bifidobacterium
species. Interestingly, subgroup analysis which separated the
effects of isolated fibres from whole foods found that
whole-food intervention of mostly grains and cereals had no
effect on Bifidobacterium abundances(14). However, the
impact of whole foods v. isolated food components on
Bifidobacterium populations is not consistent across studies.
Mandalari et al.(62) highlighted the likely importance of using
whole-food interventions over isolated fibres, demonstrating
that when almonds were consumed with all constituent parts
present (in comparison with almonds with the lipid content
removed), a significant increase in the abundance of
Bifidobacterium was observed. Taken together, these results
suggest a lack of consistency for the effects of whole foods
on the gut microbiota, highlighting the need for further research
exploring the comparative effect of whole foods and food
constituents.
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The SCFA butyrate is mainly produced by members of the
Firmicutes family including Roseburia spp. Lachnospira spp.
and Faecalibacterium prausnitzii,which belong to the clostrid-
ium clusters XIVa and IV(63). Butyrate is a major source of energy
for the colonic epithelial cells and has many well-documented
health effects, including the inhibition of colonic carcinogenesis
and acting as an anti-inflammatory agent(64). The present review
found two studies(27,31) to report a significantly increased abun-
dance of Clostridium and Roseburia, another two studies(31,33) to
report a significantly increased abundance of Lachnospira and
one study(34) to report a significant increase in an OTU closest
to Clostridium sp. ASF-356. Studies in vitro have found that
finely ground almonds increase concentrations of butyrate(62)
and that Roseburia may be a major contributor to the
butyrate-producing capacity of the gastrointestinal tract(65). As
an increased abundance of specific butyrate-producing species
was observed in the included trials listed above, it may be
inferred that this potentially resulted in a butyrogenic effect,
although further research utilising metabolomic analysis is
required to confirm this. In contrast to these findings, one
study(27) included in the review did report finding no difference
in the predicted number of bacterial butanoate metabolism
genes following walnut consumption, potentially explained by
a proportionate decrease in other butyrate-producing species
during the feeding period. Indeed, considering changes in the
microbiota as a whole may be a better indicator of the overall
metabolomic capacity of the microbiota, rather than focusing
on the isolated microbial shift in individual taxa.
In addition to bacteria, the present review also summarised
the overall effects of nut intake on fungal and archaeal popula-
tions, providing a more comprehensive picture of the human gut
microbiota. While it has previously been reported that diet-
induced shifts can modulate the populations of these
microbes(66), the review found no significant changes to the
diversity or the relative abundance of archaea, with only one
study(34) to report a decrease in various fungal OTUs following
nut intake. The small sample size of the review may account for
the differences observed in these results, as only one study
sequenced fungal DNA(34) and two studies sequenced both fun-
gal and archaeal DNA(27,31). Further research in this area is
needed in order to form a more comprehensive understanding
of fungal and archaeal activity with nut intake.
While exploring shifts in the microbiota according to nut type
was the main focus of the review, other commonalities between
studies were also investigated to identify patterns in results. One
study characteristic of interest was the feeding method utilised.
For example, three(27,31,34) of the eight studies were classified as
complete feeding trials, whereby all food provided to partici-
pants was controlled (as opposed to free-living trials where nuts
were often administered alongside general dietary recommen-
dations). Interestingly, while shifts in microbial diversity were
negligible (only one of the three studies reported a change in
β-diversity), shifts in bacterial composition were notable. In par-
ticular, two studies(27,31) reported an increase in Clostridium,
Roseburia and Dialister, all of which are known to be capable
of producing SCFA(67,68). In both studies, a run-in period of 9 d
was used to allow for the adaptation of the participant’s gut
microbiota following the change in habitual diet, increasing
the likelihood of these changes being attributable to nut intake.
While the small sample size limits the broader interpretation of
these findings, these results highlight the importance of control-
ling for participants’ background diet as a significant variable.
This review followed a robust methodology, including pro-
spective registration of the review protocol and duplicate screen-
ing and inclusion of articles. Additionally, the review only
included trials employing next-generation sequencing technol-
ogy, to ensure the most comprehensive analysis of the micro-
biota reflecting current analytical techniques, and a means of
promoting homogeneity between results. The implementation
of this exclusion criteria did mean that the evidence base for
analysis was smaller, as trials utilising other microbial determina-
tion techniques were excluded (such as bacterial culturing and
fluorescence in situ hybridisation). As a limitation, the systematic
search was restricted to scientific databases, which may have
meant that unpublished studies were not detected. Further,
the present review did not assess the metabolomic capacity of
the gut microbiota including themeasurement of SCFA, meaning
interpretation of results is limited due to the challenge of con-
necting microbial shifts to metabolic pathway activity and health
outcomes(69). The high level of heterogeneity between studies
should also be acknowledged, including the collection and
processing of biological samples, sequencing platform and com-
putational pipelines used. Also, papers differed in their statistical
analysis and reporting of gut microbial data, including the pre-
sentation of findings for different diversity metrics or only at cer-
tain taxonomic levels. Well-designed interventional trials with
larger sample sizes, reproducible methods and reporting of
results are still needed to exemplify the exact effect of nuts on
the gut microbiota.
Despite the small number of studies in this review, a large
variation in results was observed. This may be due to the intrinsi-
cally complex nature of microbiome research, with marked
differences in the inter-individual variation of subject’s gut
microbiota previously observed(48). Despite strategies to
decrease this variation such as the use of cross-over study
designs and excluding participants with gastrointestinal disease
or those on recent antibiotic therapy, large variations in the com-
position and function of individual’smicrobiota remain. Previous
research has indicated that an individual’s response to any
dietary intervention is largely dependent upon their established
gut microbiota(70). Given these findings, and the knowledge that
a patient’s habitual diet and food diversity is a major determinant
of their gut microbiota(71), a more rigorous screening and selec-
tion process including pre-intervention dietary analysis may be
warranted in an attempt to reduce the inter-microbial differences
of individual’s microbiota at baseline. In addition, several limita-
tions in the design of several included studies may have
impacted results – for example, a lack of reporting of baseline
nut consumption. Therefore, robust study designs which take
into account an individual’s baseline dietary intake, as well as
considering inter-individual gut microbiota differences are
required.










ollongong , on 15 Sep 2020 at 23:11:01 , subject to the Cam
bridge Core term







This review suggests that nut intake has the potential to yield a
modest effect on the gut microbiota, although the exact effects
are inconsistent across studies. Compared with other nut types,
walnuts appeared to be the strongest driver of overall gut micro-
bial composition (β-diversity), which may be explained by their
unique nutritional composition. Walnuts are rich in polyphenols
and n-3 fatty acids, both of which have been found to have pre-
biotic properties. Overall, it appears gutmicrobial composition is
more affected by nut intake during short-term feeding trials than
overall microbial diversity, although the small sample size of this
review limits interpretation. Further, whether these composi-
tional changes translate into tangible health outcomes remains
to be investigated, ideally with the use of more sophisticated
multi-omic methods, such as metagenomic and metabolomic
technology to evaluate the overall functional capacity of the
microbiota. Inconsistencies associated with trial design and
methodology, as well as inter-individual microbiota variances
and the vast number of potential confounding variables present
in this field of research further complicate interpretation of the
results. Future trials aiming to explore the influence of nut intake
on the gut microbiota must carefully consider study design,
ideally incorporating complete feeding methods with a single
food or nutrient modification. Additionally, an assessment of
habitual dietary pattern and baseline microbiota composition
is recommended in order to minimise the inter-individual com-
position of the gut microbiota.
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